Policy & Medicine November 30, 2024
Under recent data released by the Centers for Medicare and Medicaid Services (CMS), roughly 405 of Medicare Advantage (MA) plans with prescription drug coverage will earn at least four stars in 2025, a slight decrease from the 42% that earned four or more stars in 2024. This figure has been steadily decreasing, with 51% of plans earning four or more stars in 2023 and 68% of plans in 2022.
MA plans with prescription drug coverage are rated on up to 40 unique quality and performance measures. Each of the measures has a threshold established by CMS (known as a “cut point”) that is used to determine whether the contract’s performance for that measure receives a 1-, 2-, 3-, 4-, or...
Today's Sponsors
Today's Sponsor